Return to Trial Database

HCRN-GU15-262

Phase 2 Trial of Olaparib in Patients with Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations

Status

Study Completed

Cancer Type(s)

Bladder Urothelial Carcinoma

Study Contact

Publications

Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations

Trial Locations

All sites in which the trial HCRN-GU15-262 being conducted in.

No data was found